A CU Medicine provider.
We strive to provide patient-focused, personalized, multi-disciplinary care for gastrointestinal (GI) cancers. Our specialized providers in Medical Oncology (chemotherapy and targeted therapies), Surgical Oncology, Radiation Oncology, Pathology, Molecular Pathology, Radiology, Interventional Radiology, Nuclear Medicine, Gastroenterology (both Hepatology and Interventional Endoscopy), Nutrition, and Integrative Medicine work together to achieve the best outcomes for our patients. We have cancer-specific multidisciplinary clinics in pancreas, colorectal, gastroesophageal, liver, and neuroendocrine cancers where patients can meet all of their specialty providers in a single clinic visit.
Dr. Lieu joined the University of Colorado School of Medicine faculty in 2011. He trained in internal medicine at the University of Colorado, where he also served as a Chief Medical Resident. Dr. Lieu completed his fellowship training in medical oncology at the University of Texas MD Anderson Cancer Center and served as the Chief Medical Oncology Fellow in 2010. Dr. Lieu currently serves as the co-Director of GI Medical Oncology at the University of Colorado Cancer Center, the Vice-Chair of the National Cancer Institute Colon Cancer Task Force, the FDA Oncologic Drugs Advisory Committee (ODAC), and the National Comprehensive Cancer Network (NCCN) Panel for Neuroendocrine Cancers.
Qualifications and experience
- Cancers, Cancers - Biliary Cancer, Cancers - Cancer Medicine, Cancers - Cancer Prevention, Cancers - Colorectal Cancer, Cancers - Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver), Cancers - Pancreatic Cancer, Digestive System, Digestive System - Gastroenterology (Stomach, Bowel, General GI Problems), Internal Medicine, Medical Oncology
- Languages spoken
University of Texas M D Anderson Cancer Center Program (2011)
University of Colorado (University Hospital) Program (2005)
Wake Forest University School of Medicine (2004)
University of Colorado (University Hospital) Program (2008)
University of North Carolina–Chapel Hill (NC) (2000)
- Clinical interest for patients
I am interested in Gastrointestinal Cancers (Colorectal, Pancreatic, Gastric, Esophageal, Hepatocellular, Gallbladder, Bile Duct, Anal, Carcinoma of Unknown (Primary), Drug Development (Experimental Therapeutics) and Translational Research.
- Research interest for patients
I am a member of the Developmental Therapeutics (phase I clinical trials) and Gastrointestinal (GI) Medical Oncology Program. These comprehensive programs include multidisciplinary cancer clinics, tumor boards, and research endeavors. I am interested in resistance mechanisms to targeted therapy in GI cancers, and I was awarded the Conquer Cancer Foundation Career Development Award, NIH K23 grant, and a NIH R01 grant to study targeted therapies in colorectal cancer. I am also investigating novel therapeutic strategies to more effectively treat and prevent colorectal cancer in young adults.
- UCHealth strongly encourages you to consult with your health insurer to determine accurate information about your coverage and benefits for a particular health care service provided at a UCHealth facility. Read more here.